TA
ACOR

Teachers Advisors’s Acorda Therapeutics ACOR Stock Holding History

Teachers Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.19M Buy
1,373
+63
+5% +$113K ﹤0.01% 1927
2018
Q4 		$2.45M Hold
1,310
– – ﹤0.01% 1727
2018
Q3 		$3.09M Buy
1,310
+547
+72% +$1.69M ﹤0.01% 1733
2018
Q2 		$2.63M Buy
763
+24
+3% +$73.5K ﹤0.01% 1784
2018
Q1 		$2.1M Hold
739
– – ﹤0.01% 1808
2017
Q4 		$1.9M Buy
739
+84
+13% +$239K ﹤0.01% 1875
2017
Q3 		$1.86M Sell
655
-2
-0.3% -$5.27K ﹤0.01% 1878
2017
Q2 		$1.55M Buy
657
+48
+8% +$95.1K ﹤0.01% 1969
2017
Q1 		$1.53M Sell
609
-1,478
-71% -$4.25M ﹤0.01% 1919
2016
Q4 		$4.71M Buy
2,087
+17
+0.8% +$40.4K 0.01% 1314
2016
Q3 		$5.19M Buy
2,070
+207
+11% +$618K 0.01% 1193
2016
Q2 		$5.7M Buy
1,863
+89
+5% +$289K 0.01% 1111
2016
Q1 		$5.63M Buy
1,774
+181
+11% +$751K 0.01% 1081
2015
Q4 		$8.18M Buy
1,593
+42
+3% +$184K 0.02% 964
2015
Q3 		$4.93M Sell
1,551
-743
-32% -$2.88M 0.01% 1119
2015
Q2 		$9.18M Sell
2,294
-240
-9% -$927K 0.02% 936
2015
Q1 		$10.1M Sell
2,534
-223
-8% -$1.02M 0.02% 885
2014
Q4 		$13.5M Buy
2,757
+172
+7% +$738K 0.03% 746
2014
Q3 		$10.5M Sell
2,585
-723
-22% -$2.71M 0.02% 838
2014
Q2 		$13.4M Buy
3,308
+62
+2% +$253K 0.03% 736
2014
Q1 		$14.8M Buy
3,246
+14
+0.4% +$56.6K 0.03% 683
2013
Q4 		$11.3M Buy
3,232
+228
+8% +$889K 0.03% 755
2013
Q3 		$12.4M Buy
3,004
+22
+0.7% +$94.8K 0.03% 692
2013
Q2 		$11.8M Buy
+2,982
New +$12.3M 0.03% 650

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Teachers Advisors's ACOR Position: Q1 2019 in Review

Teachers Advisors increased its Acorda Therapeutics (ACOR) stake by 4.8% in Q1 2019, buying an estimated $113K and bringing the position to 1,373 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1927.

Teachers Advisors first reported a position in ACOR in Q2 2013 and has held it in 24 quarters since. The position peaked at $14.8M in Q1 2014. 184 funds tracked by Wall St. Rank hold ACOR as of Q1 2019.

  • Teachers Advisors held 1,373 shares of Acorda Therapeutics worth $2.19M as of Q1 2019.
  • Teachers Advisors bought 63 Acorda Therapeutics shares in Q1 2019, an estimated $113K.
  • Acorda Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1927 holding.
  • Teachers Advisors first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Acorda Therapeutics position peaked at $14.8M in Q1 2014.
  • 184 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.